Exchange: NASDAQ·Updated 09:58 PM EDT
SLS logo

SLS SELLAS Life Sciences Group Inc

$11.65
$0.04
(0.35%)
Today
Closed $11.49
$0.16
(1.39%)
Overnight
EarningsNov 11
Mkt Cap$2.32B
Vol14.61M

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
32

Bearish Sentiment

How do you feel about SLS?

Advertisement|Remove ads.